The Pharmacy Times® HIV Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of HIV, a virus that attacks the body's immune system and, if left untreated, can lead to AIDS.
September 27th 2023
The hydrogel injection has had a lasting drug concentration of 42 days with almost no adverse effects.
HIV Therapy: Addressing Unanswered Questions to Optimize Care
2.5 Credits / HIV/AIDS
View More
Oral Chemotherapy Parity Legislation: Opportunities for Cancer Care Equity
1.0 Credit / Law, Oncology
View More
Preventing and Managing Controlled Substance Diversion Across Health Care Settings
2.0 Credits / Law
View More
Risks and Liabilities in Pharmacy Practice
1.0 Credit / Law
View More
Navigating Approved Pre-exposure Prophylaxis (PrEP) Options for HIV Prevention: The Expanding Role of Pharmacists as Patient Educators and Advocates (Pharmacy Technician Credit)
2.0 Credits / HIV/AIDS
View More
Navigating Approved Pre-exposure Prophylaxis (PrEP) Options for HIV Prevention: The Expanding Role of Pharmacists as Patient Educators and Advocates (Pharmacist Credit)
2.0 Credits / HIV/AIDS
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Study: Blood Cancer Treatment Found to Kill Latent HIV-Infected Cells, Possible New Treatment
September 6th 2023Although antiretroviral therapies are the standard of care treatment for those with HIV, the drugs cannot target latent infections; however, venetoclax, a blood cancer treatment, shows promise.
Read More